Gorjana Radisic1, Janine Chapman2, Ingrid Flight3, Carlene Wilson4. 1. Flinders Centre for Innovation in Cancer, Flinders University, School of Medicine, GPO Box 2100, Adelaide SA 5001, Australia; Cancer Council SA, 202 Greenhill Road, Eastwood, SA 5063, Australia. Electronic address: gorjana.radisic@flinders.edu.au. 2. Flinders Centre for Innovation in Cancer, Flinders University, School of Medicine, GPO Box 2100, Adelaide SA 5001, Australia; Cancer Council SA, 202 Greenhill Road, Eastwood, SA 5063, Australia. Electronic address: Janine.chapman@flinders.edu.au. 3. Flinders Centre for Innovation in Cancer, Flinders University, School of Medicine, GPO Box 2100, Adelaide SA 5001, Australia; Cancer Council SA, 202 Greenhill Road, Eastwood, SA 5063, Australia. Electronic address: Ingrid.flight@flinders.edu.au. 4. Flinders Centre for Innovation in Cancer, Flinders University, School of Medicine, GPO Box 2100, Adelaide SA 5001, Australia; Cancer Council SA, 202 Greenhill Road, Eastwood, SA 5063, Australia. Electronic address: Carlene.wilson@flinders.edu.au.
Abstract
OBJECTIVE: The objective of the study was to identify factors associated with human papilloma virus (HPV) vaccine acceptability in parents of adolescent boys. This information is critical to the development of approaches to optimise HPV vaccine uptake among this population group. METHODS: We performed a systematic search of the literature in addressing factors influencing parental attitudes to and beliefs about HPV vaccine and its acceptability for use. The findings were organised within the framework of the Health Belief Model (HBM) and summarised using a semi quantitative method. RESULTS: Eighteen studies met the inclusion criteria. Parental decisions were predominantly shaped by the perceived benefits of the vaccine; perceived risk of sons contracting the HPV infection, and having recommendations from health care providers. Fear of side effects and uncertainty about vaccine effectiveness, as well as cost and lack of healthcare, were barriers to HPV vaccination. Other factors such as knowledge, family characteristics, parent-child dialogue and egalitarian values appeared to be important when deciding whether to vaccinate boys. CONCLUSIONS: HPV vaccine uptake among male adolescents is suboptimal. Future programs need to address the predictors of uptake by educating parents about the boys' high susceptibility to infection, the benefits of vaccination, and reduce concerns regarding perceived barriers. Additionally, uptake may be facilitated by encouraging health care provider endorsement, particularly in countries without government-funded immunisation programs.
OBJECTIVE: The objective of the study was to identify factors associated with human papilloma virus (HPV) vaccine acceptability in parents of adolescent boys. This information is critical to the development of approaches to optimise HPV vaccine uptake among this population group. METHODS: We performed a systematic search of the literature in addressing factors influencing parental attitudes to and beliefs about HPV vaccine and its acceptability for use. The findings were organised within the framework of the Health Belief Model (HBM) and summarised using a semi quantitative method. RESULTS: Eighteen studies met the inclusion criteria. Parental decisions were predominantly shaped by the perceived benefits of the vaccine; perceived risk of sons contracting the HPV infection, and having recommendations from health care providers. Fear of side effects and uncertainty about vaccine effectiveness, as well as cost and lack of healthcare, were barriers to HPV vaccination. Other factors such as knowledge, family characteristics, parent-child dialogue and egalitarian values appeared to be important when deciding whether to vaccinate boys. CONCLUSIONS:HPV vaccine uptake among male adolescents is suboptimal. Future programs need to address the predictors of uptake by educating parents about the boys' high susceptibility to infection, the benefits of vaccination, and reduce concerns regarding perceived barriers. Additionally, uptake may be facilitated by encouraging health care provider endorsement, particularly in countries without government-funded immunisation programs.
Authors: Milkie Vu; Carla J Berg; Cam Escoffery; Hyun M Jang; Tien T Nguyen; Lisa Travis; Robert A Bednarczyk Journal: Vaccine Date: 2020-08-20 Impact factor: 3.641
Authors: Jane Chang; Lisa S Ipp; Ariel M de Roche; Marina Catallozzi; Carmen Radecki Breitkopf; Susan L Rosenthal Journal: J Pediatr Adolesc Gynecol Date: 2017-10-13 Impact factor: 1.814
Authors: Abbey B Berenson; Jacqueline M Hirth; Erika L Fuchs; Mihyun Chang; Richard E Rupp Journal: Hum Vaccin Immunother Date: 2019-12-06 Impact factor: 3.452
Authors: Kate E Dibble; Jessica L Maksut; Elizabeth J Siembida; Morica Hutchison; Keith M Bellizzi Journal: J Adolesc Young Adult Oncol Date: 2019-05-15 Impact factor: 2.223
Authors: Amanda F Meyer; Nicole L Borkovskiy; Jennifer L Brickley; Rajeev Chaudhry; Andrew Franqueira; Joseph W Furst; Donna M Hinsch; Margaret R McDonah; Jane F Myers; Randi E Petersen; Lila J Finney Rutten; Patrick M Wilson; Robert M Jacobson Journal: Am J Prev Med Date: 2018-10-19 Impact factor: 5.043
Authors: Julie H T Dang; Susan L Stewart; Dean A Blumberg; Hector P Rodriguez; Moon S Chen Journal: Hum Vaccin Immunother Date: 2020-02-12 Impact factor: 3.452